An isolated venous sac as a novel site for cell therapy in diabetes mellitus

Transplantation

Volumn 94, Issue 4, 2012, Pages 319-324

  Kakabadze, Zurab ^a   Shanava, Koba ^a   Ricordi, Camillo ^b   Shapiro, A M James ^c   Gupta, Sanjeev ^d   Berishvili, Ekaterine ^a  

^a TBILISI STATE MEDICAL UNIVERSITY   (Georgia)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d Gottesman Institute for Stem Cell Research and Regenerative Medicine   (United States)

Author keywords

Intravascular transplantation; Islets; Pancreas

Indexed keywords

INSULIN; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DIABETES MELLITUS; ENGRAFTMENT; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HISTOPATHOLOGY; MALE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; VASCULAR ACCESS; VEIN BLOOD FLOW;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; PORTAL VEIN; RATS; RATS, INBRED LEW; SAPHENOUS VEIN; STREPTOZOCIN;

EID: 84865656948     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31825e4a83     Document Type: Article

References (24)

1. Ricordi C. Islet transplantation: A brave new world. Diabetes 2003; 52: 1595.
2. Ricordi C, Strom TB. Clinical islet transplantation: advances and im-munological challenges. Nat Rev Immunol 2004; 4: 259.
3. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free im-munosuppressive regimen. N Engl J Med 2000; 343: 230.
4. Harlan DM, Kenyon NS, Korsgren O, et al. Immunology of Diabetes Society. Current advances and travails in islet transplantation. Diabetes 2009; 58: 2175.
5. Vantyghem MC, Kerr-Conte J, Arnalsteen L, et al. Primary graft function, metabolic control, and graft survival after islet transplantation. Diabetes Care 2009; 32: 1473.
6. Bellin MD, Barton FB, Heitman A, et al. Potent induction immuno-therapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am J Transplant 2012;12: 1576.
7. Hiller WF, Klempnauer J, Luck R, et al. Progressive deterioration of endocrine function after intraportal but not kidney subcapsular rat islet transplantation. Diabetes 1991; 40: 134.
8. Scharp DW, Marchetti P, Swanson C, et al. The effect of transplantation site and islet mass on long-term survival and metabolic and hormonal function of canine purified islet autografts. Cell Transplant 1992; 1: 245.
9. Mattsson G, Jansson L, Carlsson PO. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes 2002; 51: 1362.
10. Carlsson PO, Palm F, Andersson A, et al. Chronically decreased oxygen tension in rat pancreatic islets transplanted under the kidney capsule. Transplantation 2000; 69: 761.
11. Kakabadze Z, Gupta S, Brandhorst D, et al. Long-term engraftment and function of transplanted pancreatic islets in vascularized segments of small intestine. Transpl Int 2011; 24: 175.
12. Echeverri GJ, McGrath K, Bottino R, et al. Endoscopic gastric sub-mucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs. Am J Transplant 2009; 9: 2485.
13. Caiazzo R, Gmyr V, Hubert T, et al. Evaluation of alternative sites for islet transplantation in the minipig: interest and limits of the gastric submucosa. Transplant Proc 2007; 39: 2620.
14. Kriz J, Jirak D, Vilk GJ, et al. Vascularization of artificial beds for pancreatic islet transplantation in a rat model. Transplant Proc 2010; 42: 2097.
15. Pileggi A, Molano RD, Ricordi C, et al. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 2006; 81: 1318.
16. Bottino R, Fernandez LA, Ricordi C, et al. Transplantation of alloge-neic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 1998; 47: 316.
17. BennetW, Sundberg B, Groth CG, et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 1999; 48: 1907.
18. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002; 360: 2039.
19. Brissova M, Fowler M, Wiebe P, et al. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes 2004; 53: 1318.
20. Linn T, Schneider K, Hammes HP, et al. Angiogenic capacity of en-dothelial cells in islets of Langerhans. FASEB J 2003; 17: 881.
21. Nyqvist D, Kohler M, Wahlstedt H, et al. Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts. Diabetes 2005; 54: 2287.
22. Human P, Franz T, Scherman J, et al. Dimensional analysis of human saphenous vein grafts: implications for external mesh support. J Thorac Cardiovasc Surg 2009; 137: 1101.
23. Lametschwandtner A, Minnich B, Kachlik D, et al. Three-dimensional arrangement of the vasa vasorum in explanted segments of the aged human great saphenous vein: scanning electron microscopy and three-dimensional morphometry of vascular corrosion casts. Anat Rec A Discov Mol Cell Evol Biol 2004; 281: 1372.
24. Lescalié F, Germouty I, Chevalier JM, et al. Extrinsic arterial supply of the great saphenous vein: an anatomic study. Ann Vasc Surg 1986; 1: 273.